Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of Subjects to Determine Eligibility to Safely Participate in Blood Disorders Studies

NCT00695123 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00695123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00695123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of Subjects to Determine Eligibility to Safely Participate in Blood Disorders Studies
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
July 3, 2008
Completion date
April 2, 2021
Enrollment
816 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow transplant, g-csf, sickle cell disease